Christine Gilles

Christine Gilles

Auto-generated profile, based on publicly available information

Christine Gilles

GIGA-Cancer, Laboratory of Tumor and Development Biology, University of Liège, Liège, Belgium

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2010 in Journal of Mammary Gland Biology and Neoplasia
Verified
Journal Article
Closed access
PDF file
ABArnaud Bonnomet
Arnaud Bonnomet
ABAnne Brysse
Anne Brysse
ATAnthony Tachsidis
Anthony Tachsidis
MWMark Waltham
Mark Waltham
ETErik Walter Thompson
Erik Walter Thompson
CGChristine Gilles
Christine Gilles

15 May 2003
Verified
Journal Article
Closed access
CGChristine Gilles
Christine Gilles
MPMyriam Polette
Myriam Polette
MMMélanie Mestdagt
Mélanie Mestdagt
BNBeatrice Nawrocki-Raby
Beatrice Nawrocki-Raby
PRPhilippe Ruggeri
Philippe Ruggeri
JFJean-Michel Foidart
Jean-Michel Foidart

27 March 2006 in Oncogene
Verified
Journal Article
Closed access
SBS Bindels
S Bindels
MMM Mestdagt
M Mestdagt
CVC Vandewalle
C Vandewalle
NJN Jacobs
N Jacobs
LVL Volders
L Volders
CGC Gilles
C Gilles

15 August 2001 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
CGChristine Gilles
Christine Gilles
MPMyriam Polette
Myriam Polette
CCChristelle Coraux
Christelle Coraux
JTJean-Marie Tournier
Jean-Marie Tournier
GMGuerrino Meneguzzi
Guerrino Meneguzzi
JFJean-Michel Foidart
Jean-Michel Foidart
Membrane-type matrix metalloproteinase 1 (MT1-MMP) is a membrane-anchored matrix metalloproteinase (MMP) that is frequently associated with processes involving tissue remodelling and cell migration. We have examined MT1-MMP expression and subcellular distribution as a function of MCF10A mammary epithelial cell migration using an in vitro outgrowth migration assay. Stronger expression of MT1-MMP was observed at the mRNA and at the protein level in cells at the periphery of the outgrowth. As shown by videomicroscopy,these cells were involved in an orientated cell migration, in contrast to stationary cells distant from the periphery. Furthermore, MT1-MMP was mainly distributed in lamellipodia of migratory cells, as well as at their basal surface in contact with the substrate. Laminin-5 (Ln-5), a recently described substrate for MT1-MMP, was deposited preferentially in the matrix by migratory cells. Fragments of the γ2 subunit of Ln-5 were also identified in migratory cultures of MCF10A cells, attesting to its proteolytic degradation. These fragments corresponded in size to those we observed after incubation of purified human Ln-5 with the recombinant catalytic domain of human MT1-MMP. We also show that anti-Ln5 blocking antibodies, MMP inhibitors (BB94 and TIMP-2)and MT1-MMP antisense oligonucleotides significantly decreased MCF10A cell migration. Taken together, these observations demonstrate that MT1-MMP is spatially and temporally regulated during MCF10A cell migration, and suggest that MT1-MMP-mediated pericellular proteolysis of Ln-5 γ2 chain could contribute to this process.

26 May 2017 in Developmental Dynamics
Verified
Journal Article
Closed access
PDF file
MFMarie‐Emilie Francart
Marie‐Emilie Francart
JLJustine Lambert
Justine Lambert
AVAline M. Vanwynsberghe
Aline M. Vanwynsberghe
ETErik Walter Thompson
Erik Walter Thompson
MBMorgane Bourcy
Morgane Bourcy
CGChristine Gilles
Christine Gilles

14 July 2016 in Cancer Research
Verified
Journal Article
Open access
PDF file
MBMorgane Bourcy
Morgane Bourcy
MSMeggy Suarez-Carmona
Meggy Suarez-Carmona
JLJustine Lambert
Justine Lambert
MFMarie-Emilie Francart
Marie-Emilie Francart
HSHélène Schroeder
Hélène Schroeder
CGChristine Gilles
Christine Gilles
Epithelial–mesenchymal transition (EMT) is prominent in circulating tumor cells (CTC), but how it influences metastatic spread in this setting is obscure. Insofar as blood provides a specific microenvironment for tumor cells, we explored a potential link between EMT and coagulation that may provide EMT-positive CTCs with enhanced colonizing properties. Here we report that EMT induces tissue factor (TF), a major cell-associated initiator of coagulation and related procoagulant properties in the blood. TF blockade by antibody or shRNA diminished the procoagulant activity of EMT-positive cells, confirming a functional role for TF in these processes. Silencing the EMT transcription factor ZEB1 inhibited both EMT-associated TF expression and coagulant activity, further strengthening the link between EMT and coagulation. Accordingly, EMT-positive cells exhibited a higher persistance/survival in the lungs of mice colonized after intravenous injection, a feature diminished by TF or ZEB1 silencing. In tumor cells with limited metastatic capability, enforcing expression of the EMT transcription factor Snail increased TF, coagulant properties, and early metastasis. Clinically, we identified a subpopulation of CTC expressing vimentin and TF in the blood of metastatic breast cancer patients consistent with our observations. Overall, our findings define a novel EMT–TF regulatory axis that triggers local activation of coagulation pathways to support metastatic colonization of EMT-positive CTCs. Cancer Res; 76(14); 4270–82. ©2016 AACR.